位置:首页 > 蛋白库 > GPR62_MOUSE
GPR62_MOUSE
ID   GPR62_MOUSE             Reviewed;         358 AA.
AC   Q80UC6; Q8CEQ6;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   02-OCT-2007, sequence version 2.
DT   03-AUG-2022, entry version 100.
DE   RecName: Full=G-protein coupled receptor 62;
GN   Name=Gpr62;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 17-120.
RX   PubMed=12679517; DOI=10.1073/pnas.0230374100;
RA   Vassilatis D.K., Hohmann J.G., Zeng H., Li F., Ranchalis J.E.,
RA   Mortrud M.T., Brown A., Rodriguez S.S., Weller J.R., Wright A.C.,
RA   Bergmann J.E., Gaitanaris G.A.;
RT   "The G protein-coupled receptor repertoires of human and mouse.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4903-4908(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 271-358.
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, MUTAGENESIS
RP   OF ALA-111 AND 232-GLY--LEU-237, SUBUNIT, AND FUNCTION.
RX   PubMed=28912303; DOI=10.1530/rep-17-0333;
RA   Muroi T., Matsushima Y., Kanamori R., Inoue H., Fujii W., Yogo K.;
RT   "GPR62 constitutively activates cAMP signaling but is dispensable for male
RT   fertility in mice.";
RL   Reproduction 154:755-764(2017).
CC   -!- FUNCTION: Orphan G-protein coupled receptor. Constitutively activates
CC       the G(q/11)/inositol phosphate and the G(s)-alpha/cAMP signaling
CC       pathways (PubMed:28912303). Has spontaneous activity for beta-arrestin
CC       recruitment (By similarity). Shows a reciprocal regulatory interaction
CC       with the melatonin receptor MTNR1B most likely through receptor
CC       heteromerization (By similarity). {ECO:0000250|UniProtKB:Q9BZJ7,
CC       ECO:0000269|PubMed:28912303}.
CC   -!- SUBUNIT: Homodimer (PubMed:28912303). Forms heterodimer with MTNR1B (By
CC       similarity). Interacts with ARRB1 and ARRB2 in a spontaneous and
CC       agonist-independent manner; leading to the internalization of GPR62 in
CC       the endosomal compartment (By similarity).
CC       {ECO:0000250|UniProtKB:Q9BZJ7, ECO:0000269|PubMed:28912303}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9BZJ7};
CC       Multi-pass membrane protein {ECO:0000255}. Endosome membrane
CC       {ECO:0000250|UniProtKB:Q9BZJ7}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Colocalizes with ARRB2 in the endosome.
CC       {ECO:0000250|UniProtKB:Q9BZJ7}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain and testes. Expressed
CC       widely, in the brain, including the cerebral cortex, cerebellum,
CC       hippocampus,thalamus and pituitary gland. In the testes, expressed
CC       specifically in the germ cells. {ECO:0000269|PubMed:28912303}.
CC   -!- DEVELOPMENTAL STAGE: Expression in the testes starts 25 days after
CC       birth and continues thereafter. {ECO:0000269|PubMed:28912303}.
CC   -!- DOMAIN: Lacks the conserved DRY and BBXXB motifs. The restoration of
CC       these motifs affects its constitutive activity.
CC       {ECO:0000269|PubMed:28912303}.
CC   -!- DISRUPTION PHENOTYPE: Deficient mice show any abnormality in growth and
CC       behavior. Both male and female are fertile.
CC       {ECO:0000269|PubMed:28912303}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC151729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK016613; BAC25490.1; -; mRNA.
DR   EMBL; AY255551; AAO85063.1; -; mRNA.
DR   CCDS; CCDS52909.1; -.
DR   RefSeq; NP_001153124.1; NM_001159652.1.
DR   RefSeq; XP_006511830.1; XM_006511767.3.
DR   AlphaFoldDB; Q80UC6; -.
DR   SMR; Q80UC6; -.
DR   STRING; 10090.ENSMUSP00000129055; -.
DR   GlyGen; Q80UC6; 1 site.
DR   iPTMnet; Q80UC6; -.
DR   PhosphoSitePlus; Q80UC6; -.
DR   SwissPalm; Q80UC6; -.
DR   PaxDb; Q80UC6; -.
DR   PRIDE; Q80UC6; -.
DR   ProteomicsDB; 271071; -.
DR   Antibodypedia; 14225; 228 antibodies from 29 providers.
DR   Ensembl; ENSMUST00000164834; ENSMUSP00000129055; ENSMUSG00000091735.
DR   GeneID; 436090; -.
DR   KEGG; mmu:436090; -.
DR   UCSC; uc012gzw.1; mouse.
DR   CTD; 118442; -.
DR   MGI; MGI:3525078; Gpr62.
DR   VEuPathDB; HostDB:ENSMUSG00000091735; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00950000182998; -.
DR   HOGENOM; CLU_067115_0_0_1; -.
DR   InParanoid; Q80UC6; -.
DR   OMA; RPPRACT; -.
DR   OrthoDB; 1373348at2759; -.
DR   PhylomeDB; Q80UC6; -.
DR   TreeFam; TF332667; -.
DR   BioGRID-ORCS; 436090; 1 hit in 73 CRISPR screens.
DR   PRO; PR:Q80UC6; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q80UC6; protein.
DR   Bgee; ENSMUSG00000091735; Expressed in lumbar subsegment of spinal cord and 78 other tissues.
DR   Genevisible; Q80UC6; MM.
DR   GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; ISO:MGI.
DR   GO; GO:1990763; F:arrestin family protein binding; ISS:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IMP:UniProtKB.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048016; P:inositol phosphate-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; ISO:MGI.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Endosome; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..358
FT                   /note="G-protein coupled receptor 62"
FT                   /id="PRO_0000305584"
FT   TOPO_DOM        1..17
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        18..38
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        39..53
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        54..74
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        75..89
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        90..110
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        111..128
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        129..149
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        150..176
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        177..197
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        198..234
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        235..255
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        256..268
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        269..289
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        290..358
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          334..358
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        3
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         111
FT                   /note="A->D: No effect on constitutive activity; No effect
FT                   on protein level; Does not affect homooligomerization."
FT                   /evidence="ECO:0000269|PubMed:28912303"
FT   MUTAGEN         232..237
FT                   /note="GGKAAL->KKAAKT: Strong decreases on constitutive
FT                   activity; No effect on protein level; Does not affect
FT                   homooligomerization."
FT                   /evidence="ECO:0000269|PubMed:28912303"
SQ   SEQUENCE   358 AA;  37148 MW;  6FC222684565B5D6 CRC64;
     MANGSGLSVT ELAGSVGFIL AVLVEVGAVL GNGTLLVVVL RTPDLQDAFY LAHLCVVDLL
     AAASIMPLGL LAAPPGLGTV PLDPSSCRAA RFLSAALLPA CTLGVAALGL ARYRLIVHPL
     RPGARPAPAL VLTAVWSAAA LLGALSLLGP PPAPPPAPAR CSVLAGGLGP FRPLWAMLAF
     ALPALLLLAA YGSIFLVARR AALRPPRGTR PRSDSLDSRL SFLPPLRPRL LGGKAALAPA
     LAVGQFAACW LPYGCACLAP AARAAAAEAT VTWVAYSAFA AHPFLYGLLQ RPVRLALGRL
     TRRALPRAPK ACTSQAWHLQ TLLRRLQELR KDPVLGPSEA PEQARELARQ TPSVSEAT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024